Transform Allergy Care. Together.
Resources
Join thousands of providers worldwide referring patients to the Food Allergy Institute. Powered by data and guided by science, our team helps children and adults achieve remission from food allergies through the Tolerance Induction Program® (TIP).
Provider Guides
Data Dashboards
2024 FAI Insights
Publications
Long-Term Efficacy and Safety of Cow's Milk Anaphylaxis Specific Immunotherapy
Food anaphylaxis diagnostic marker compilation in machine learning design and validation
Tolerance Induction Program Effect Explains Variation in Wheal Size, sIgE, and IgG4 in Peanut Allergic Children
Demographic, clinical and diagnostic correlation of almond allergy in a cohort of nut allergy patients
Experimental evaluation of the importance of colonization history in early-life gut microbiota assembly
Correlation of negative skin-prick test results for tree nuts and successful tree nut challenges
Webinars & Grand Rounds
Living With Food Freedom - May Webinar
Immune System Insights - April 2025 Webinar
June Webinar: Our Care Model With Dr. Randhawa & Mia
Living Food Freedom with Dr. Inderpal Randhawa and Holly Leatherman
Understanding Food Labels
Tolerance Induction Program® Videos
What is TIP?
What Is The Food Allergy Institute?
Day in the Life of a TIP Patient
TIP FAQ: Bio Similar Proteins
TIP FAQ: Cross-Contamination
TIP FAQ: What is Food Allergy Remission
CME Courses
Evolving Perspectives CME
New CME Comming Soon
Provider Testimonials
Lidia Mohtasham, M.D.
Omar Yamak, M.D
Steven Abelowitz
Michael Villadelgado
Joseph Statos
Atoosha Kourosh
Providers FAQs
Clinical questions about protocols, patient selection, and treatment management.
-
What are the main clinical differences between TIP and OIT?
TIP offers a safer, more advanced, and personalized path to food freedom compared to OIT’s desensitization-based approach.
Safety – TIP is designed to be safer, minimizing reaction risk through a data-driven, personalized approach, whereas OIT carries a higher risk of allergic reactions due to direct allergen exposure.
Treatment Goal – TIP aims for true remission, allowing patients to eat freely without ongoing maintenance, while OIT focuses on desensitization, requiring lifelong daily dosing to maintain tolerance.Personalization – TIP uses AI-driven immune profiling to customize treatment for each patient based on biomarkers, whereas OIT follows a standardized protocol for individual allergens.
Multi-Allergen Treatment – TIP treats multiple food allergies simultaneously, while OIT typically targets one allergen at a time.
Diagnostic Testing & Monitoring – TIP relies on advanced diagnostics (IgE, IgG4, skin prick, basophil activation tests) to track immune shifts, while OIT has limited ongoing immune monitoring.
Dosing & Lifestyle Impact – TIP eliminates lifelong dosing and rest periods, allowing a more flexible lifestyle, whereas OIT requires strict daily dosing and and activity restrictions.
-
What type of patient is a good candidate for TIP?
TIP is for patients with IgE-mediated food allergies, regardless of severity or preexisting conditions.
Ideal candidates include children and young adults with multiple food allergies or a history of severe reactions, seeking a long-term solution beyond avoidance.
-
How is the Tolerance Induction Program informed by clinical research, and what is the function of your dedicated research division?
TPIRC, our research branch and parent company, operates as a cutting-edge medical research institute focused on advancing treatments for food allergies and rare orphan disease. It conducts clinical research, develops diagnostic tools, and through the Baric Data Loop, generates the data that powers TIP’s precision-based approach. By continuously analyzing patient outcomes and refining treatment protocols, TPIRC helps improve safety, efficacy, and long-term success for food allergy patients.
Learn more about the B.A.R.I.C Data Loop -
How is TIP regulated? Under what regulatory agencies?
TIP, along with our diagnostic lab, research facility, and biobank, follows regulated standards set by the FDA and is overseen by our Institutional Review Board (IRB) Advarra, ensuring the highest levels of safety and compliance. We are also accredited and regulated by CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), the California Department of Public Health, the U.S. Department of Health and Human Services, and the Medical Board of California. Additionally, our food lab's gummy doses are sent to a third party to verify the accurate protein dosage in each gummy.